Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application

Scopio Labs: The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care. TEL AVIV, Israel, – April 17, 2024 – Scopio Labs, developer of Full-Field Digital...

Your invitation from the Bigpicture Project:  We are excited to invite you to the first Bigpicture Community Meeting, themed ‘The Digital Transformation of Pathology’. During the online meeting, Prof. Jeroen van der Laak, WP1 Bigpicture...

Indica Labs: Supercharge your Image analysis with AI-powered HALO 4.0 AI-Powered Pathology with HALO®, HALO AI, and HALO Link 4.0 Date: 6 June 2024 Time: 7:00 – 8:00 PDT | 10:00 – 11:00 EDT | 15:00 – 16:00...

Charles River and Deciphex: Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices April 11, 2024 08:00 AM Eastern Daylight Time WILMINGTON, Mass....

From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various diseases, including cancer. Traditionally, pathologists manually count...

LEHI, UT, April 11, 2024 – Lumea Inc., a forefront innovator in the digital pathology space, is pleased and honored to be announced the winner of Utah’s Best in State award for Medical Innovation. Lumea operates right in the heart of...